MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1 d.
30. jūn., 22:00:00 GMT+2 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Stock Titan
·
pirms 13 minūtēm
About 1.4 million gallons of renewable diesel were shipped by XCF Global in September.
Simply Wall Street
·
pirms 2 minūtēm
Can One Year DM1 Data Change The Bull Case For Dyne Therapeutics Stock?
ChartMill
·
pirms 33 minūtēm
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Pairs Strong Growth With a High-Quality Technical Setup
CNBC
·
pirms 55 minūtēm
S&P 500 futures are mixed ahead of bank earnings
Profils
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia